The treatment of ankylosing spondylitis |
| |
Authors: | K.J. Scalapino J.C. Davis Jr. |
| |
Affiliation: | (1) Division of Rheumatology, The University of California San Francisco, 533 Parnassus Avenue, Box 0633, Room U383, San Francisco, CA 94143, USA. jdavis@medicine.ucsf.edu, US |
| |
Abstract: | Ankylosing spondylitis is an inflammatory disorder affecting the axial skeleton and periphery. Symptoms can often be debilitating. Current therapy for the disease include physical therapy, non-steroidal anti-inflammatory drugs (NSAIDS, anti-rheumatic disease modifying drugs (DMARDS), and the newly developed biologic agents targeting tumor necrosis factor alpha (TNF-α). This paper will provide a comprehensive review of these treatments which focusing on evidence based medicine for the daily clinical practice of rheumatology. Received: 31 December 2002 / Accepted: 15 January 2003 Correspondence to J.C. Davis Jr. |
| |
Keywords: | Ankylosing spondylitis Medical therapies NSAIDS Physical therapy Sulfasalazine Pamidronate Thalidomide Methotrexate Biologic agents TNF |
本文献已被 PubMed SpringerLink 等数据库收录! |
|